» Articles » PMID: 18539238

Pulmonary Sarcoidosis

Overview
Journal Clin Chest Med
Specialty Pulmonary Medicine
Date 2008 Jun 10
PMID 18539238
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis is an inflammatory granulomatous disease that is characterized by diverse organ system manifestations, a variable clinical course, and a predilection for affecting relatively young adults worldwide. Abnormalities on chest radiographs are detected in 85% to 95% of patients who have sarcoidosis. Approximately 20% to 50% of patients who have sarcoidosis present with respiratory symptoms, including dyspnea, cough, chest pain, and tightness of the chest. The clinical course and manifestations of pulmonary sarcoidosis are protean: spontaneous remission occurs in approximately two thirds of patients; up to 30% of patients have chronic course of the lung disease, resulting in progressive, (sometimes life-threatening) loss of lung function. Morbidity that correlates to sarcoidosis occurs in 1% to 4% of patients.

Citing Articles

First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna.

Guttmann-Ducke C, Lutnik M, Gysan M, Sarova P, Milacek C, Bal C Sci Rep. 2025; 15(1):8644.

PMID: 40082706 PMC: 11906772. DOI: 10.1038/s41598-025-93708-9.


Exertional Dyspnea Incidentally Diagnosed as Sarcoidosis: A Teaching Hospital Experience.

Nartey M, Ulzen-Appiah K Case Rep Pulmonol. 2023; 2023:8689352.

PMID: 37706114 PMC: 10497360. DOI: 10.1155/2023/8689352.


Pleural involvements in pulmonary sarcoidosis: A case report and review of the literature.

Ji X, Lu J, Zuo A, Sun F, Peng H, Lu D Front Med (Lausanne). 2022; 9:902711.

PMID: 36465916 PMC: 9709110. DOI: 10.3389/fmed.2022.902711.


Sarcoidosis in the Middle East.

Jayakrishnan B, Al-Busaidi N, Al-Mubaihsi S, Al-Rawas O Ann Thorac Med. 2019; 14(2):106-115.

PMID: 31007761 PMC: 6467024. DOI: 10.4103/atm.ATM_227_18.


Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study.

Sjodin M, Checa A, Yang M, Dahlen S, Wheelock A, Eklund A Respir Res. 2018; 19(1):236.

PMID: 30509266 PMC: 6276236. DOI: 10.1186/s12931-018-0939-0.